BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15275721)

  • 1. Acute urinary retention after transperineal template-guided prostate biopsy.
    Buskirk SJ; Pinkstaff DM; Petrou SP; Wehle MJ; Broderick GA; Young PR; Weigand SD; O'Brien PC; Igel TC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1360-6. PubMed ID: 15275721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk.
    Igel TC; Knight MK; Young PR; Wehle MJ; Petrou SP; Broderick GA; Marino R; Parra RO
    J Urol; 2001 May; 165(5):1575-9. PubMed ID: 11342920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The morbidity of transperineal template-guided prostate mapping biopsy.
    Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
    BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores.
    Pepe P; Aragona F
    Urology; 2013 Jun; 81(6):1142-6. PubMed ID: 23726443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive transperineal template biopsies of prostate: modified technique and results.
    Bott SR; Henderson A; Halls JE; Montgomery BS; Laing R; Langley SE
    Urology; 2006 Nov; 68(5):1037-41. PubMed ID: 17095067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
    Stone NN; Marshall DT; Stone JJ; Cesaretti JA; Stock RG
    J Urol; 2010 Feb; 183(2):634-9. PubMed ID: 20018308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.
    Williams SG; Millar JL; Duchesne GM; Dally MJ; Royce PL; Snow RM
    Radiother Oncol; 2004 Oct; 73(1):33-8. PubMed ID: 15465143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W; Nakanishi H; Ochiai A; Babaian KN; Troncoso P; Babaian RJ
    J Urol; 2007 Jul; 178(1):111-4. PubMed ID: 17499289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review.
    Ikeda T; Shinohara K
    Int J Urol; 2009 Jun; 16(6):558-60. PubMed ID: 19456987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of transrectal versus transperineal prostate biopsy.
    Miller J; Perumalla C; Heap G
    ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
    Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M
    Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy.
    Satoh T; Matsumoto K; Fujita T; Tabata K; Okusa H; Tsuboi T; Arakawa T; Irie A; Egawa S; Baba S
    Urology; 2005 Jul; 66(1):114-8. PubMed ID: 15992910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.